MCLEAN, Va., April 25, 2018 -- Verato, Inc., a leading provider of SaaS-based patient matching and customer matching solutions, is excited to announce that Black Book™, a leading healthcare technology research company, ranked Verato third out of 27 enterprise master patient index (EMPI) vendors in its most recent list of highest-rated vendors. Black Book surveyed 1,392 health technology managers to generate its ranking of the 27 EMPI vendors.
The Verato Universal™ MPI, which Verato launched less than a year ago, is a next-generation master patient index solution. It is one of the first and only SaaS-based EMPIs built for the cloud—compared to many other vendors’ “cloud-based” EMPIs, which are simply hosted versions of on-premises legacy software. It is also one of the first and only EMPIs to use the power of Referential Matching to make matches that no traditional EMPI can ever make—compared to many other EMPIs, whose accuracy is highly dependent on the quality of the underlying patient data they are matching.
“The Verato Universal MPI is the fastest to deploy, easiest to implement, most cost effective, and most accurate EMPI solution on the market,” said Mark LaRow, CEO of Verato. “Despite that, it is still remarkable that we are already ranked third by such a prestigious independent research company when our solution has only been on the market for less than a year. We look forward to being ranked first next year—as more organizations want to combine the simplicity of the cloud with the power of Referential Matching to solve their rapidly growing patient matching needs.”
Verato is the only vendor on Black Book’s list whose technology is so accurate and so easy to implement that it is often deployed alongside incumbent EMPI technologies to make them better. This popular solution, called Verato Auto-Steward™, is a SaaS-based plug-in that uses the same powerful Referential Matching technology as the Verato Universal MPI. Organizations can use Verato Auto-Steward to seamlessly integrate with their existing EMPI technology and automatically resolve the “potential duplicates” that the EMPI can’t resolve without manual review by a data steward. Verato Auto-Steward automatically resolves up to 75% of an EMPI’s “potential duplicate” task list and significantly reduces an organization’s investment in manual duplicate review.
Between the Verato Universal MPI and Verato Auto-Steward, Verato’s Referential Matching technology is being used by health systems, payers, HIEs, and other organizations across the country to match over 45% of the US population to date and growing.
“Time and again we hear in conversations how frustrated organizations are with their existing EMPIs,” said Jason Bihun, VP of Sales at Verato. “The conventional EMPI technologies offered by the other vendors on Black Book’s list are expensive to deploy and maintain, yet they aren’t very accurate. But Verato solutions are unconventional—they’re cloud-based and so accurate that they don’t require tuning or overly burdensome data governance. Organizations ready to transition to a SaaS-based EMPI solution can deploy the Verato Universal MPI in as little as 4 months and never have to worry again about forced software upgrades or periodic clean-ups. But organizations that aren’t ready to replace their existing EMPI can still make it much better by deploying Verato Auto-Steward in as little as 6 weeks.”
About Verato
Verato offers a cloud-based matching platform that links and matches identities across disparate databases or organizations with the highest accuracy rates in the industry. Verato leverages an extensive self-learning database of U.S. identities as a reference, or universal “answer key.” And because it is cloud-based, the Verato platform is less expensive, faster to implement, and more scalable than traditional matching technology. Verato is based in McLean, VA. For more information, visit www.verato.com.
Media Contact:
Jim Lubinskas
Spire Communications
[email protected]
703.907.9103


Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
How Marco Pharma International Preserves German Homeopathic Traditions in America
Anthropic’s Claude AI Reportedly Used in U.S. Operation to Capture Nicolas Maduro
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer 



